Drug Resistance, Viral

Vaccines and Antiviral Agents
Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)
Catherine S. Adamson, Kayoko Waki, Sherimay D. Ablan, Karl Salzwedel, Eric O. Freed
Vaccines and Antiviral Agents
Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance
Kristie D. Ibarra, Julie K. Pfeiffer
Vaccines and Antiviral Agents
Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor
Katrina M. Nolan, Gregory Q. Del Prete, Andrea P. O. Jordan, Beth Haggarty, Josephine Romano, George J. Leslie, James A. Hoxie
Vaccines and Antiviral Agents
The Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation I132M Confers Hypersensitivity to Nucleoside Analogs
Zandrea Ambrose, Brian D. Herman, Chih-Wei Sheen, Shannon Zelina, Katie L. Moore, Gilda Tachedjian, Dwight V. Nissley, Nicolas Sluis-Cremer
Vaccines and Antiviral Agents
HR-2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR-1 Mutations That Cause Clinical Resistance to Enfuvirtide
Neelanjana Ray, Leslie A. Blackburn, Robert W. Doms
Vaccines and Antiviral Agents
Non-Cleavage Site Gag Mutations in Amprenavir-Resistant Human Immunodeficiency Virus Type 1 (HIV-1) Predispose HIV-1 to Rapid Acquisition of Amprenavir Resistance but Delay Development of Resistance to Other Protease Inhibitors
Manabu Aoki, David J. Venzon, Yasuhiro Koh, Hiromi Aoki-Ogata, Toshikazu Miyakawa, Kazuhisa Yoshimura, Kenji Maeda, Hiroaki Mitsuya
Pathogenesis and Immunity
Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals
Stéphane Hué, Robert J. Gifford, David Dunn, Esther Fernhill, Deenan Pillay
and on Behalf of the UK Collaborative Group on HIV Drug Resistance
Genetic Diversity and Evolution
Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen
Mariacarmela Solmone, Donatella Vincenti, Mattia Carlo Felice Prosperi, Alessandro Bruselles, Giuseppe Ippolito, Maria Rosaria Capobianchi
Vaccines and Antiviral Agents
Active-Site Mutations in the South African Human Immunodeficiency Virus Type 1 Subtype C Protease Have a Significant Impact on Clinical Inhibitor Binding: Kinetic and Thermodynamic Study
Salerwe Mosebi, Lynn Morris, Heini W. Dirr, Yasien Sayed
Vaccines and Antiviral Agents
Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral-Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations
Yumi Mitsuya, Vici Varghese, Chunlin Wang, Tommy F. Liu, Susan P. Holmes, Prerana Jayakumar, Baback Gharizadeh, Mostafa Ronaghi, Daniel Klein, W. Jeffrey Fessel, Robert W. Shafer

Pages